MeCP2 confers 5-fluorouracil resistance in gastric cancer via upregulating the NOX4/PKM2 pathway.
Yannan QinXiaoping MaChen GuoShuang CaiHailin MaLing-Yu ZhaoPublished in: Cancer cell international (2022)
MeCP2 confers 5-FU resistance in GC cells via upregulating the NOX4/PKM2 pathway, which may lead to a promising therapeutic strategy for GC.